Eculizumab an anti-C5 monoclonal antibody is used in the treatment of:
Correct Answer: Paroxysmal nocturnal hemoglobinuria
Description: A major advance in the management of PNH has been the development of a humanized monoclonal antibody, eculizumab, directed against the complement component C5. By blocking the complement cascade downstream of C5, eculizumab abrogates complement-dependent intravascular hemolysis in all PNH patients. Reference: Harrisons Principles of Internal Medicine, 18th Edition, Pages 884-86
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now